Is modified Devine exclusion necessary for gastrojejunostomy in patients with unresectable pancreatobiliary cancer?

Surg Today. 2011 Jan;41(1):97-100. doi: 10.1007/s00595-009-4246-8. Epub 2010 Dec 30.

Abstract

Purpose: Gastrojejunostomy is often performed as palliative surgery for unresectable pancreatobiliary cancer. Modified Devine exclusion (MDE) is a technical variation of gastrojejunostomy, which partially separates the mid-portion of the stomach. We conducted this study to assess whether MDE is necessary for gastrojejunostomy in patients with unresectable pancreatobiliary cancer.

Methods: We compared the postoperative results of MDE (n = 26) with those of conventional gastrojejunostomy (CGJ; n = 20) performed palliatively for unresectable pancreatobiliary cancers.

Results: The morbidity rates were 38% after MDE and 50% after CGJ, with 23% and 40% of patients suffering delayed gastric emptying, respectively. Two of the CGJ group patients could never eat again. Modified Devine exclusion slowed the progression of anemia in all of the patients with duodenal bleeding.

Conclusion: Modified Devine exclusion may be effective for patients with unresectable pancreatobiliary cancer.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Duct Neoplasms / complications
  • Bile Duct Neoplasms / pathology
  • Bile Duct Neoplasms / surgery*
  • Cohort Studies
  • Female
  • Gallbladder Neoplasms / complications
  • Gallbladder Neoplasms / pathology
  • Gallbladder Neoplasms / surgery*
  • Gastric Bypass / methods*
  • Humans
  • Male
  • Middle Aged
  • Palliative Care*
  • Pancreatic Neoplasms / complications
  • Pancreatic Neoplasms / pathology
  • Pancreatic Neoplasms / surgery*
  • Patient Selection
  • Retrospective Studies
  • Treatment Outcome